A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

When an RSV vaccine became available for use during pregnancy, it offered a natural experiment between various countries to see how it compared to a one-time antibody injection ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

WSOC Charlotte. FDA approves new RSV treatment for infants. Posted: June 11, 2025 | Last updated: June 11, 2025. More for You ...

Colds and flu often cause sore throats that make swallowing and talking uncomfortable, while RSV in adults and older children usually mimics a mild cold. Cepacol® explores why sore throats are more ...

The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid ... (RSV) cases among infants aged 0-7 months during the October 2024 to February 2025 ...

An antibody treatment for respiratory syncytial virus (RSV) appears to be more effective at protecting infants from severe illness than vaccination during pregnancy. About 100,000 children ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

CHARLOTTE — The Food and Drug Administration approved a new vaccine to help protect infants from RSV on Monday. The treatment is called Enflonsia. It is a monoclonal antibody made by Merck. It ...